Holen Sie sich die Stockscreener-App
1.505
9.06%
-0.15
Handel nachbörslich:
1.52
0.015
+1.00%
Schlusskurs vom Vortag:
$1.655
Offen:
$1.66
24-Stunden-Volumen:
2.09M
Relative Volume:
0.90
Marktkapitalisierung:
$104.73M
Einnahmen:
$151.64M
Nettoeinkommen (Verlust:
$-37.23M
KGV:
-3.8452
EPS:
-0.3914
Netto-Cashflow:
$-21.18M
1W Leistung:
-25.50%
1M Leistung:
+11.48%
6M Leistung:
-31.59%
1J Leistung:
-66.03%
1-Tages-Spanne:
$1.50
$1.66
1-Wochen-Bereich:
$1.50
$2.475
52-Wochen-Spanne:
$0.80
$4.8495
Neuronetics Inc Stock (STIM) Company Profile
Firmenname
Neuronetics Inc
Sektor
Branche
Telefon
877-600-7555
Adresse
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
1.505 | 115.17M | 151.64M | -37.23M | -21.18M | -0.3914 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2018-07-24 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Neuronetics Inc Aktie (STIM) Neueste Nachrichten
MSN Money - MSN
Neuronetics (STIM) Q1 2026 Earnings Transcript - AOL.com
Neuronetics outlines $160M-$166M 2026 revenue outlook with focus on $2.5M-$3M annualized cost savings - MSN
Full Transcript: Neuronetics Q1 2026 Earnings Call - Sahm
Neuronetics, Inc. (NASDAQ:STIM) Q1 2026 Earnings Call Transcript - Insider Monkey
Neuronetics Q1 2026 slides: revenue rises 8% amid profitability push By Investing.com - Investing.com Australia
Geopolitical Turmoil and Supply Chain Strains Threaten Neuronetics’ Costs, Margins, and Growth - TipRanks
Neuronetics Q1 Earnings Call Highlights - Yahoo Finance
Neuronetics, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Neuronetics STIM Stock Jumps As Activist Pressure Meets Growth Tailwinds - StocksToTrade
Neuronetics Grants Inducement Awards to Six New Employees - MyChesCo
Neuronetics Q1 2026 slides: revenue rises 8% amid profitability push - Investing.com
Neuronetics, Inc. 1Q 2026: Revenue $34.45M, EPS ($0.16) — 10-Q Summary - TradingView
Earnings call transcript: Neuronetics Q1 2026 shows revenue growth despite EPS miss - Investing.com
Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Debt covenants and going concern warning weigh on Neuronetics (NASDAQ: STIM) - Stock Titan
Neuronetics Posts Q1 Revenue Growth and Expanded TMS Coverage - TipRanks
Neuronetics : STIM Corporate Presentation May 2026 - marketscreener.com
Q1 2026 Neuronetics Inc Earnings Call Transcript - GuruFocus
Neuronetics Inc (NASDAQ:STIM) Posts Narrower Loss in Q1 2026, Pre-Market Rises Despite Revenue Miss - ChartMill
Neuronetics Reports First Quarter 2026 Financial and Operating Results - The Manila Times
NEURONETICS ($STIM) Releases Q1 2026 Earnings - Quiver Quantitative
Neuronetics (NASDAQ: STIM) posts 8% Q1 2026 revenue growth and updates 2026 outlook - Stock Titan
Neuronetics: Q1 Earnings Snapshot - KVUE
Optum policy change opens NeuroStar TMS to 34.8M covered lives - Stock Titan
BRIEF-Neuronetics Q1 Gross Margin 46.9% - TradingView
Neuronetics, Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2026 - marketscreener.com
Neuronetics (STIM) Margin Compression Reinforces Bearish Clinic Mix Narrative - Sahm
How The Neuronetics (STIM) Investment Story Is Evolving With A Reset Price Target - Yahoo Finance
Neuronetics Inc expected to post a loss of 17 cents a shareEarnings Preview - TradingView
Short Interest in Neuronetics, Inc. (NASDAQ:STIM) Rises By 16.4% - MarketBeat
STIM SEC FilingsNeuronetics 10-K, 10-Q, 8-K Forms - Stock Titan
Earnings Preview: Neuronetics to Report Financial Results Pre-market on May 05 - Moomoo
Neuronetics CFO Steven Pfanstiel to depart; company begins search for successor - MSN
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Primer: Neuronetics Inc (STIM US)Apr 2026 - Smartkarma
New Neuronetics hires get stock awards that vest over up to 4 years - Stock Titan
Why is STIM stock rallying 16% after-hours? - MSN
Neuronetics (STIM) Projected to Post Earnings on Tuesday - MarketBeat
STIMNeuronetics Inc Stock Price and Quote - Finviz
Neuronetics Schedules Q1 2026 Earnings Release and Call - MyChesCo
Neuronetics (STIM) price target increased by 44.44% to 4.42 - MSN
Neuronetics targets $40M–$43M Q4 revenue as SPRAVATO mix drives full-year outlook - MSN
Finanzdaten der Neuronetics Inc-Aktie (STIM)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):